Housing & Shelter
National Breast Cancer Coalition Fund
WASHINGTON, DC
Total revenue
$4.5M
Total expenses
$4.0M
Net assets
$6.6M
Grants received
$8.5M
144 grants
EIN
521782065
Tax year
2024
Mission
Nbcc's mission is "to end breast cancer through the power of action and advocacy."
Programs
5 programs
Catalytic research projects and collaborations - nbcc's artemis project is centered around strategic summits, catalytic workshops, and collaborative efforts with a multi- disciplinary and diverse group of stakeholders. This advocate-led, innovative approach allows scientists, industry representatives, and regulators to work collaboratively with advocates to develop and implement strategic research plans that could have a significant impact on primary prevention and saving lives. Projects include:- artemis project for a preventive breast cancer vaccine: a strategic plan for the development of a preventive in breast cancer.- artemis project on the preventive of metastasis: determining the process by which breast cancer spreads and becomes lethal, and how to intervene to stop it. - seed grants for research: nbcc has awarded seed grants to allow scientists to begin the research required in key areas identified in the collaborative research plans.clinical trials initiative - nbcc works with industry and the research community on clinical trials that meet the criteria of nbcc's clinical trial project. We involve breast cancer activists in all aspects of clinical trial design, implementation, and oversight. We work to improve access to quality clinical trials and, thus, treatment and care for women with breast cancer and strategies for those at risk.
Public policy - public policy plays a significant role in all aspects of breast cancer. Nbcc focuses its public policy advocacy on priorities that will have a major impact on ending breast cancer, including those that will increase funding for meaningful breast cancer research, provide access to high-quality health care and clinical trials, and expand the influence of breast cancer advocates everywhere breast cancer decisions are made.nbcc provides members of congress and their staff up-to-date information about breast cancer and reports on research discoveries that affect policy and appropriations. Nbcc leadership often testifies before congressional committees on substantive breast cancer issues.
Public information, communications, and outreach - nbcc has undertaken an expansive effort to change the conversation around breast cancer to a dialogue about knowing how to end the disease.- breast cancer information campaigns: the nbcc website and print and electronic communications help educate the public with facts about breast cancer. Nbcc's expert staff analyze research studies and media coverage and present the truth behind the news.- global influence: the nbcc executive team, board of directors, and advocate leadership represent the breast cancer community, advocating on its behalf and serving on scientific, medical, and research bodies at the national and international levels.through all of these programs, nbcc supports and facilitates the research needed to end breast cancer, global access to the necessary information and lifesaving interventions, and the influence of leaders everywhere in the strategies to end breast cancer.
Grassroots advocacy field network development and support - nbcc provides resources and support to member organizations nationwide and enhances education and training among diverse populations of breast cancer activists.all organization and individual members of nbcc's national action network receive email alerts throughout the year, usually twice each month, with important information and timely actions for their advocacy. Nbcc also convenes regular conference calls and webinars for the grassroots field network to provide individualized guidance, informational materials, and peer-to-peer support.
Other programs - through the clinical trials initiative, nbcc works with the research community to involve breast cancer activists in all aspects of clinical trial design, implementation and oversight and increase the number of high quality trials conducted.
Financials
FY 2024
Revenue
Expenses
People
20 listed
FRANCES VISCO
PRESIDENT
$221K
46 hrs/wk
MARA WALKER
CHIEF PROGRAMS OFFICER
$185K
38 hrs/wk
DENNIS SLAMON MD
TRUSTEE
—
1 hrs/wk
DOUGLAS WALL
TRUSTEE
—
1 hrs/wk
LIANE LINDNER
TRUSTEE
—
1 hrs/wk
BRYAN JOHNS
TRUSTEE
—
1 hrs/wk
ANN YAHNER
TRUSTEE
—
1 hrs/wk
BETH EMERY
TRUSTEE
—
1 hrs/wk
TODD NICKEY
TRUSTEE
—
1 hrs/wk
JUDI HIRSHFIELD-BARTEK
TRUSTEE
—
1 hrs/wk
SHERRY GOLDMAN
TRUSTEE
—
1 hrs/wk
IRA HILLMAN
TREASURER
—
1 hrs/wk
LINDA ROTHWEILER
SECRETARY
—
1 hrs/wk
MICHELE RAKOFF
VICE CHAIR
—
1 hrs/wk
ALEC CALL
CHAIR
—
1 hrs/wk
MICHELLE TREGEAR
CHIEF ADVANCEMENT OFFICER
$182K
39 hrs/wk
MARY DULANEY
CHIEF OPERATING OFFICER
$167K
38 hrs/wk
NICOLE LEVINS
COMMUNICATIONS DIRECTOR
$151K
38 hrs/wk
MELANIE WYNE
CHIEF POLICY OFFICER
$147K
32 hrs/wk
MARGARET BUSH
DIRECTOR, GRASSROOTS ENGAG
$114K
37 hrs/wk
Grants received
Showing 144 of 144
Funded by
$8.5M from 58 funders · 144 grants · 2017–2024
$3.4M · 4 grants · 2020–2024
$1.7M · 7 grants · 2020–2024
$518K · 8 grants · 2017–2023
$472K · 2 grants · 2022–2023
$399K · 3 grants · 2020–2024
$250K · 2 grants · 2022–2023
$211K · 6 grants · 2019–2024
$200K · 5 grants · 2019–2024